Literature DB >> 19618113

Primary CNS anaplastic diffuse large B-cell lymphoma mimicking undifferentiated metastatic tumors: a case report.

Tianyu Yang1, Shawn Belverud, Albert Y Yeh, Jela Bandovic, Peter Farmer, Rona F Woldenberg, Alexis Demopoulos, Michael Schulder, Jian Yi Li.   

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare intracranial tumor, with an annual incidence of six per million population. Anaplastic variant of primary CNS diffuse large B-cell lymphoma is less common; to our knowledge, there is only one other case report in the world literature. We describe a 71 year old immunocompetent female without significant past medical history who presented with confusion and a homogeneously enhancing midline mass. The patient underwent craniotomy for tumor biopsy, followed by high-dose methotrexate-based chemotherapy despite a remarkably low performance status. Histologically, this tumor was composed of undifferentiated polymorphic tumor cells, multi-nucleated giant cells, extensive necrosis, and conspicuous mitotic activity, mimicking undifferentiated metastatic tumors. Immunohistochemical stains demonstrated immunopositivity of tumor cells for CD20, MUM-1, and BCL-6, and negative staining for CD3, CD10, and CD30. The clinical course, diagnostic workup, pathologic correlates, and treatment outcomes are described.

Entities:  

Mesh:

Year:  2009        PMID: 19618113     DOI: 10.1007/s11060-009-9974-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  6 in total

1.  Detection of Epstein-Barr virus DNA and expression of CD30 antigen in primary anaplastic diffuse large B-cell lymphoma of the brain.

Authors:  T Shimura; Y Sugisaki; K Fukino; Y Node; A Teramoto; M Kawamoto
Journal:  Brain Tumor Pathol       Date:  2001       Impact factor: 3.298

Review 2.  Primary CNS lymphoma.

Authors:  Elizabeth Gerstner; Tracy Batchelor
Journal:  Expert Rev Anticancer Ther       Date:  2007-05       Impact factor: 4.512

3.  Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.

Authors:  Igor T Gavrilovic; Adília Hormigo; Joachim Yahalom; Lisa M DeAngelis; Lauren E Abrey
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

4.  BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.

Authors:  Kristina M Braaten; Rebecca A Betensky; Laurence de Leval; Yoshifumi Okada; Fred H Hochberg; David N Louis; Nancy L Harris; Tracy T Batchelor
Journal:  Clin Cancer Res       Date:  2003-03       Impact factor: 12.531

Review 5.  Primary CNS lymphoma.

Authors:  Tracy Batchelor; Jay S Loeffler
Journal:  J Clin Oncol       Date:  2006-03-10       Impact factor: 44.544

6.  Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.

Authors:  S Bhagavathi; A Sharathkumar; S Hunter; L Sung; R Kanhere; M D Venturina; J D Wilson
Journal:  Clin Neuropathol       Date:  2008 Jan-Feb       Impact factor: 1.368

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.